SCHEMBL6510139

SCHEMBL6510139

CC(C)CNC(=O)c1ccc2c(=O)c3c(sc2c1)CC(C)(C)CC3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.37
MAPK14 Q16539 1/20 0.37
KIF11 P52732 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4D Q08499 1/20 0.37
CNR2 P34972 1/20 0.37
SLC34A2 O95436 2/20 0.37
MLYCD O95822 1/20 0.36
NAMPT P43490 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
POLB P06746 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNA1I Q9P0X4 1/20 0.34
FABP4 P15090 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6504028 0.87 MAPK14 (0.41) KMT2AHPGDKDM4EMEN1MAPK14
SCHEMBL5742423 0.83 LMNA (0.35) KMT2AHSD17B10MEN1KIF11PDE4B
SCHEMBL5741839 0.82 RXRA (0.37) KIF11PDE4BPDE4DSLC34A2FABP4
SCHEMBL6506308 0.81 KIF11 (0.44) HPGDKIF11SLC34A2MLYCDLMNA
SCHEMBL5739318 0.79 KIF11 (0.32) KIF11PDE4BPDE4DSLC34A2FABP4
SCHEMBL5739316 0.77 PDE4B (0.33) PDE4BPDE4D
SCHEMBL5739313 0.77 PDE4B (0.33) PDE4BPDE4D
SCHEMBL5740408 0.76 SLC34A2 (0.35) KIF11PDE4BPDE4DSLC34A2CACNA1G
SCHEMBL5740285 0.75 CYP26A1 (0.40) KMT2AGAAHSD17B10HPGDKDM4E
SCHEMBL6508440 0.75 KIF11 (0.34) KIF11PDE4BPDE4DSLC34A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009820-A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases BAYER HEALTHCARE AG (DE) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009820-A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases HTT, HMOX1, SNCA KMT2A 3255/4885GAA 1156/4885HSD17B10 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.